Trending...
- Chicago: Mayor Brandon Johnson Celebrates 10-Year Anniversary Of Dyett High School Hunger Strike
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- Prostate Cancer Survivor's Podcast Grows Audience And Builds Marketing Muscle
Download
CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
"Accessing real-world data from across a variety of sources provides rich evidence for better decision-making and improved clinical outcomes for patients," said Tom Langan, Allscripts President and Chief Commercial Officer. "We're pleased to demonstrate how Veradigm provides tools that contribute to public health initiatives, like the Covid-19 Dashboard guiding outreach to underserved communities, or identifying risk factors with research that supports patients diagnosed with NASH earlier in their diagnosis or treatment."
Key data presentations at ISPOR 2022 include:
Covid-19
Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US. L. Kallenbach. CODE: EPH60. May 17th 9:45 AM – 1:15 PM EDT.
More on illi News
SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM – 1:15 PM EDT.
NASH
Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH141. May 18th 9:00 AM – 12:45 PM EDT.
Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.
Diabetes
Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 - 6:30 PM EDT.
Artificial Intelligence (AI)
Categorizing Telemedicine Visits Using Natural Language Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th 3:00 - 6:30 PM EDT.
Evaluating a Privacy Preserving Record Linkage (PPRL) Solution to Link De-identified Patient Records in RWD Using Default Matching Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May 17th 3:00 - 6:30 PM EDT.
More on illi News
Additional presentations at ISPOR include Veradigm's Comparing Registry and Electronic Health Record (EHR) Data for Real-World Evidence Generation: Heart Failure as a Case Study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fheor-resources%2Fpresentations-database%2Fpresentation%2Fintl2022-3489%2F14151&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Comparing+Registry+and+Electronic+Health+Record+%28EHR%29+Data+for+Real-World+Evidence+Generation%3A+Heart+Failure+as+a+Case+Study&index=8&md5=44147095a4667c3af4af470e212a4b5c) on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines how generating real-world evidence (RWE) from heart failure patients requires clinical data elements not commonly found in administrative databases and has the potential to further understanding in heart failure management. Data were compared and contrasted from two different data sources, Veradigm's PINNACLE® Registry, a large cardiovascular disease registry developed by the American College of Cardiology, with those identified in the Practice Fusion ambulatory electronic health record (EHR) database.
For more presentation information titles, please visit ISPOR 2022 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fconferences-education%2Fconferences%2Fupcoming-conferences%2Fispor-2022&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=ISPOR+2022&index=9&md5=cdd4b8d795dfdba36c6e84bd0e720b00).
About Veradigm®
Veradigm® is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Only Veradigm does it all. In combination with Veradigm's companies and solutions, the Veradigm Network features a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.veradigm.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.veradigm.com&index=10&md5=c9c7e881e7286bf61b7c9fce467f916f), or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.allscripts.com&index=11&md5=7936ac5e4218d8cae96733b8a669ab77), Twitter (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twitter.com%2Fallscripts&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Twitter&index=12&md5=a1383a286347cebcdcdd4485b2dcf603), YouTube (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FAllscriptsTV&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=YouTube&index=13&md5=9629ac2282994724aae38a500a0c7871) and It Takes A Community: The Allscripts Blog (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fblog.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=It+Takes+A+Community%3A+The+Allscripts+Blog&index=14&md5=e5405b3ef183a45268980cc13a20eb0a).
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
"Accessing real-world data from across a variety of sources provides rich evidence for better decision-making and improved clinical outcomes for patients," said Tom Langan, Allscripts President and Chief Commercial Officer. "We're pleased to demonstrate how Veradigm provides tools that contribute to public health initiatives, like the Covid-19 Dashboard guiding outreach to underserved communities, or identifying risk factors with research that supports patients diagnosed with NASH earlier in their diagnosis or treatment."
Key data presentations at ISPOR 2022 include:
Covid-19
Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US. L. Kallenbach. CODE: EPH60. May 17th 9:45 AM – 1:15 PM EDT.
More on illi News
- Cars.com Names Top EV Picks as Nearly 50% of Shoppers Accelerate Purchases Ahead of Federal EV Tax Credit Expiration Sept. 30 USA - English USA - English
- Open Art Call | The Art of Artificial Intelligence | Copenhagen
- Premieres of 10th Annual NY Dog Film Festival & 8th Annual NY Cat Film Festival on Sunday, October 26, 2025 to Benefit Animal Lighthouse Rescue
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM – 1:15 PM EDT.
NASH
Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH141. May 18th 9:00 AM – 12:45 PM EDT.
Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.
Diabetes
Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 - 6:30 PM EDT.
Artificial Intelligence (AI)
Categorizing Telemedicine Visits Using Natural Language Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th 3:00 - 6:30 PM EDT.
Evaluating a Privacy Preserving Record Linkage (PPRL) Solution to Link De-identified Patient Records in RWD Using Default Matching Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May 17th 3:00 - 6:30 PM EDT.
More on illi News
- Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
- HeartcoR Solutions Expands Suite of Remote Patient Monitoring Devices, Creating a One-Stop Shop for Clinical Trial Partners
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
Additional presentations at ISPOR include Veradigm's Comparing Registry and Electronic Health Record (EHR) Data for Real-World Evidence Generation: Heart Failure as a Case Study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fheor-resources%2Fpresentations-database%2Fpresentation%2Fintl2022-3489%2F14151&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Comparing+Registry+and+Electronic+Health+Record+%28EHR%29+Data+for+Real-World+Evidence+Generation%3A+Heart+Failure+as+a+Case+Study&index=8&md5=44147095a4667c3af4af470e212a4b5c) on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines how generating real-world evidence (RWE) from heart failure patients requires clinical data elements not commonly found in administrative databases and has the potential to further understanding in heart failure management. Data were compared and contrasted from two different data sources, Veradigm's PINNACLE® Registry, a large cardiovascular disease registry developed by the American College of Cardiology, with those identified in the Practice Fusion ambulatory electronic health record (EHR) database.
For more presentation information titles, please visit ISPOR 2022 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ispor.org%2Fconferences-education%2Fconferences%2Fupcoming-conferences%2Fispor-2022&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=ISPOR+2022&index=9&md5=cdd4b8d795dfdba36c6e84bd0e720b00).
About Veradigm®
Veradigm® is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Only Veradigm does it all. In combination with Veradigm's companies and solutions, the Veradigm Network features a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.veradigm.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.veradigm.com&index=10&md5=c9c7e881e7286bf61b7c9fce467f916f), or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=www.allscripts.com&index=11&md5=7936ac5e4218d8cae96733b8a669ab77), Twitter (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twitter.com%2Fallscripts&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=Twitter&index=12&md5=a1383a286347cebcdcdd4485b2dcf603), YouTube (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.youtube.com%2FAllscriptsTV&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=YouTube&index=13&md5=9629ac2282994724aae38a500a0c7871) and It Takes A Community: The Allscripts Blog (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fblog.allscripts.com%2F&esheet=52715398&newsitemid=20220511005419&lan=en-US&anchor=It+Takes+A+Community%3A+The+Allscripts+Blog&index=14&md5=e5405b3ef183a45268980cc13a20eb0a).
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
Filed Under: Business
0 Comments
Latest on illi News
- Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
- IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
- Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- CU Aerospace DUPLEX Satellite headed to the ISS on SpaceX NG-23 Mission
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Mather Goes Bold to Challenge Society's Views on Aging
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- MooreSuccess Gaming Launches Digi 995: Color Protocol – A Futuristic Coloring Experience
- A New Era in Healthcare Marketing
- Chicago: Mayor Brandon Johnson Signs 'Right to Protest' Executive Order
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)